Latanoprost
SIGMA/L1167 - ≥98% (HPLC)
Synonym: Isopropyl (5Z,9α,11α,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate; Isopropyl (Z)-7-[(1R,2R,3R,5S)
CAS Number: 130209-82-4
Empirical Formula (Hill Notation): C26H40O5
Molecular Weight: 432.59
MDL Number: MFCD00216074
Linear Formula: C26H40O5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | colorless to yellow |
| form | oil |
| InChI | 1S/C26H40O5/c1-19(2)31-26 |
| InChI key | GGXICVAJURFBLW-CEYXHVGTSA |
| originator | Johnson & Johnson |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | CC(C)OC(=O)CCCC=C/C[C@H] |
| solubility | DMSO: freely soluble |
| methanol: soluble | |
| storage temp. | −20°C |
| Application: | Latanoprost has been used: • in the preparation of thermo-sensitive hydrogel consisting of curcumin-loaded nanoparti • as an ester pro-drug to study its effects on the murine ocular surface in mice. • in the preparation of thermo-sensitive hydrogel to study its effects on controlling ocular hypertension. |
| Biochem/physiol Actions: | Latanoprost is a potent, selective prostaglandin F2α analog receptor agonist. It is hydrolyzed by esterases into its biologically active form latanoprost acid in the cornea. Latanoprostplays a role in reducing the intraocular pressure (IOP) due to which it has therapeutic effects in treating glaucoma. |
| Features and Benefits: | This compound is featured on the Prostanoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Johnson & Johnson . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 1, 5 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

